A recent study highlights the possible adverse effect of a treatment frequently used by seniors to regulate function thyroid. The results suggest a link between the use of this medication and the acceleration of bone loss in people elderly, thus raising important questions about the management of osteoporosis and appropriate medical prescription.
Medication issues and bone health
Hormonal treatment, previously considered beneficial for problems of thyroid, finds itself at the center of controversy after the publication of research indicating a negative impact on bone mineral density. Scientists observed that the drug, although essential in the treatment of hypothyroidism, could promote bone demineralization when used by individuals of a certain age.
Usual treatment under supervision
The use of the levothyroxine, a replacement hormone for the thyroid, appears to be a common practice in elderly patients. But the results of a recent study indicate that, even when following recommended dosages, its use may be associated with a reduction in bone density in this population. This observation calls for increased vigilance and personalized monitoring in the prescription of this medication.
The question of unnecessary prescriptions
Part of the problem lies in the overprescription of this medication for cases where the diagnosis of hypothyroidism remains uncertain. The study points to a significant proportion of potentially unjustified prescriptions, which could lead to a thyroid imbalance shocking negatively the bone health of the patients concerned.
Prevention and actions for better bone health
To limit the risks of osteoporosis, it is advisable to adopt preventive measures such as a diet rich in calcium, the practice physical exercises and adequate exposure to soleil to synthesize the vitamin D. It is also essential that patients taking levothyroxine scrupulously follow the recommendations for use in order to optimize the effectiveness of the treatment while minimizing its side effects.
This study reveals a worrying aspect associated with a commonly prescribed medication and invites health professionals to rethink their approach to prescribing, especially among seniors. A balance must be struck between therapeutic needs and the prevention of potentially serious adverse effects, such as loss of bone mass leading to osteoporosis.
